“…The viruses used included 11 primary isolates of subtype B (FIV-M2, -M3, -M19, -M22, -M45, -M73, -M82, -M88, -M91, -M92, and -M97) described in a previous report (10), one primary isolate of subtype A (FIV-GL8; kind gift of Os Jarrett, Glasgow, United Kingdom), and one TCA strain of subtype A (FIVPet; kindly provided by J. K. Yamamoto, Gainesville, Fla.). The viral stocks consisted of cell-free supernatant of chronically infected FL4 cells (FIV-Pet [70]) or of acutely infected MBM cells (all other viruses). Titration of the viral stocks was carried out in MBM cells and, depending on experiment design, included or did not include washout of unadsorbed virus after 5 h at 37°C to reproduce the conditions used in the FIV inhibition assay (see below).…”